Challenges in studies of the genetic basis of Type 2 diabetes

References

• Zimmet P, Alberti KG, Shaw J. Global and societal complications of the diabetic epidemic. Nature414, 782–787 (2001).
   PubMed Web of Science ®Google Scholar
• Mokdad AH, Ford ES, Browman BA et al. Diabetes trends in the US: 1990–1998. Diabetes Care23, 1278–1283 (2000).
   PubMed Web of Science ®Google Scholar
• Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care27, 1047–1053 (2004).
   PubMed Web of Science ®Google Scholar
• Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world – a growing challenge. N. Engl. J. Med.356, 213–215 (2007).
   PubMed Web of Science ®Google Scholar
• Kahn CR. Insulin action, diabetogenes, and the cause of Type II diabetes. Diabetes43, 1066–1082 (1994).
   PubMed Web of Science ®Google Scholar
• Kahn SE. The importance of β-cell failure for the development and progression of Type 2 diabetes. J. Clin. Endocrinol. Metab.86, 4047–4058 (2001).
   PubMed Web of Science ®Google Scholar
• Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and Type 2 diabetes. Nature444, 840–846 (2006).
   PubMed Web of Science ®Google Scholar
• Groop LC, Tuomi T. Non-insulin dependent diabetes mellitus – a collision between thrifty genes and an affluent society. Ann. Med.29, 37–53 (1997).
   PubMed Web of Science ®Google Scholar
• Meigs J, Cupples L, Wilson P. Parental transmission of Type 2 diabetes: the Framingham Offspring Study. Diabetes49, 2201–2207 (2000).
   PubMed Web of Science ®Google Scholar
• Barnett AH, Eff C, Leslie RD, Pyke DA. Diabetes in identical twins. A study of 200 pairs. Diabetologia20, 87–93 (1981).
   PubMed Web of Science ®Google Scholar
• Kaprio J, Tuomilehto J, Koskenvuo M et al. Concordance for Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia35, 1060–1067 (1992).
   PubMed Web of Science ®Google Scholar
• Poulsen P, Kyvik KO, Vaag A, Beck-Nielsen H. Heritability of Type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance – a population-based twin study. Diabetologia42, 139–145 (1999).
   PubMed Web of Science ®Google Scholar
• Medici F, Hawa M, Ianari A, Pyke DA, Leslie RD. Concordance rate for Type II diabetes mellitus in monozygotic twins: actuarial analysis. Diabetologia42, 146–150 (1999).
   PubMedGoogle Scholar
• King H, Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group. Diabetes Care16, 157–177 (1993).
   PubMed Web of Science ®Google Scholar
• Fajans SS, Conn JW. Prediabetes, subclinical diabetes and latent clinical diabetes, interpretation, diagnosis and treatment. In: On the Nature and Treatment of Diabetes. Leibel DS, Wrenshall GS (Eds), Excerpta Medica, Amsterdam, Holland, 641–656 (1965).
   Google Scholar
• Tattersall RB, Fajans SS. A difference between the inheritance of classical juvenile-onset and maturity-onset type diabetes of young people. Diabetes24, 44–53 (1975).
   PubMed Web of Science ®Google Scholar
• Ledermann HM. Maturity-onset diabetes of the young (MODY) at least ten times more common than previously assumed? Diabetologia38, 1482 (1995).
   PubMed Web of Science ®Google Scholar
• Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N. Engl. J. Med.345, 971–980 (2001).
   PubMed Web of Science ®Google Scholar
• Froguel P, Vaxillaire M, Sun F et al. Close linkage of glucokinase locus on chromosome 7p to early onset non-insulin-dependent diabetes mellitus. Nature356, 162–164 (1992).
   PubMed Web of Science ®Google Scholar
• Yamagata K, Furuta H, Oda N et al. Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young MODY1. Nature384, 458–460 (1996).
   PubMed Web of Science ®Google Scholar
• Yamagata K, Odai N, Kaisaki PJ et al. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young MODY3. Nature384, 455–458 (1996).
   PubMed Web of Science ®Google Scholar
• Horikawa Y, Iwasaki N, Hara M et al. Mutation in hepatocyte nuclear factor-1β gene (TCF2) associated with MODY. Nat. Genet.17, 384–385 (1997).
   PubMed Web of Science ®Google Scholar
• Stoffers DA, Ferrer J, Clarke WL, Habener JF. Early-onset Type-II diabetes mellitus MODY4 linked to IPF1. Nat. Genet.17, 138–139 (1997).
   PubMed Web of Science ®Google Scholar
• Malecki MT, Jhala US, Antonellis A et al. Mutations in NEUROD1 are associated with the development of Type 2 diabetes mellitus. Nat. Genet.23, 323–328 (1999).
   PubMed Web of Science ®Google Scholar
• Huopio H, Otonkoski T, Vauhkonen I, Reimann F, Ashcroft FM, Laakso M. A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1. Lancet361, 301–307 (2003).
   PubMedGoogle Scholar
• Ballinger SW, Shoffner JM, Hedaya EV et al. Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nat. Genet.1, 11–15 (1992).
   PubMed Web of Science ®Google Scholar
• Van den Ouweland JM, Lemkes HH, Ruitenbeek W et al. Mutation in kmitochondrial tRNA (Leu) (UUR) gene in a large pedigree with maternally transmitted Type II diabetes and deafness. Nat. Genet.1, 368–371 (1991).
   Google Scholar
• Knouff C, Auwerx J. Peroxisome proliferator-activated receptor-γ calls for activation in moderation: lessons from genetics and pharmacology. Endocrin. Rev.25, 899–918 (2004).
   PubMed Web of Science ®Google Scholar
• Tiffin N, Adie E, Turner F et al. Computational disease gene identification: a concert of methods prioritizes Type 2 diabetes and obesity candidate genes. Nucl. Acids Res.34, 3067–3081 (2006).
   Web of Science ®Google Scholar
• Freeman H, Cox RD. Type 2 diabetes: a cocktail of genetic discovery. Hum. Mol. Genet.15, R202–R209 (2006).
   PubMedGoogle Scholar
• Horikawa Y, Oda N, Cox NJ et al. Genetic variation in the gene encoding calpain-10 is associated with Type 2 diabetes mellitus. Nat. Genet.26, 163–175 (2000).
   PubMed Web of Science ®Google Scholar
• Song Y, Niu T, Manson JE, Kwiatkowski DJ, Liu S. Are variants in the CAP10 gene related to risk of Type 2 diabetes? A quantitative assessment of population and family-based association studies. Am. J. Hum. Genet.74, 208–222 (2004).
   Web of Science ®Google Scholar
• Tsuchiya T, Schwarz PE, Bosque-Plata LD et al. Association of the calpain-10 gene with Type 2 diabetes in Europeans: results of pooled and meta-analyses. Mol. Genet. Metab.89, 174–184 (2006).
   PubMedGoogle Scholar
• Reynisdottir I, Thorleifsson G, Benediktsson R et al. Localisation of a susceptibility gene for Type 2 diabetes to chromosome 5q34-q35.2. Am. J. Hum. Genet.73, 323–335 (2003).
   PubMedGoogle Scholar
• Grant SFA, Thorleifsson G, Reynisdottir I et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of Type 2 diabetes. Nat. Genet.38, 320–323 (2006).
   PubMed Web of Science ®Google Scholar
• Zeggini E, McCarthy MI. TCF7L2: the biggest story in diabetes genetics since HLA? Diabetologia50, 1–4 (2007).
   PubMed Web of Science ®Google Scholar
• Deeb SS, Fajans L, Nemoto M et al. A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat. Genet.20, 284–287 (1998).
   PubMed Web of Science ®Google Scholar
• Altshuler D, Hirschhorn JN, Lannemark M et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of Type 2 diabetes. Nat. Genet.26, 76–80 (2000).
   PubMed Web of Science ®Google Scholar
• Gloyn AL, Weedon MN, Owen KR et al. Large-scale association studies of variants in genes encoding the pancreatic β-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with Type 2 diabetes. Diabetes52, 568–572 (2003).
   PubMed Web of Science ®Google Scholar
• Love-Gregory LD, Wasson J, Ma J et al. A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4 gene on chromosome 20q is associated with Type 2 diabetes and appears to contribute to the evidence for linkage in an Ashkenazi Jewish population. Diabetes53, 1134–1140 (2004).
   PubMed Web of Science ®Google Scholar
• Silander K, Mohlke KL, Scott LJ et al. Genetic variation near the hepatocyte nuclear factor-4α gene predicts susceptibility to Type 2 diabetes. Diabetes53, 1141–1149 (2004).
   PubMed Web of Science ®Google Scholar
• Baroso I, Luan J, Middelberg RPS et al. Candidate gene association study in Type 2 diabetes indicates a role for genes involved in β-cell function as well as insulin action. PLoS Biology1, 41–55 (2003).
   Google Scholar
• Andrulionyte L, Laukkanen O, Chiasson JL, Laakso M for the STOP-NIDDM Study Group. Single nucleotide polymorphisms in the promoter of the HNF4α gene are associated with the conversion to Type 2 diabetes: the STOP-NIDDM trial. J. Mol. Med.84, 701–708 (2006).
   PubMed Web of Science ®Google Scholar
• Hegele RA, Cao H, Harris SB, Hanley AJ, Zinman B. Hepatocyte nuclear factor-1α G319S. A private mutation in Oji-Cree associated with Type 2 diabetes. Diabetes Care22, 524 (1999).
   PubMed Web of Science ®Google Scholar
• Holmkvist J, Cervin C, Lyssenko V et al. Common variants in HNF-1α and risk of Type 2 diabetes. Diabetologia49, 2882–2891 (2006).
   PubMed Web of Science ®Google Scholar
• Rose CS, Ek J, Urhammer SA et al. A-30G>A polymorphism of the β-cell-specific glucokinase promoter associated with hyperglycemia in the general population of whites. Diabetes54, 3026–3031 (2005).
   PubMed Web of Science ®Google Scholar
• Cargill M, Altshuler D, Ireland J et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat. Genet.22, 231–238 (1999).
   PubMed Web of Science ®Google Scholar
• Miettinen O. S. The “case–control” study: valid selection of subjects. J. Chronic Dis.38, 543–548 (1985).
   PubMedGoogle Scholar
• Bhatti P. Sigurdson AJ, Wang SS et al. Genetic variation and willingness to participate in epidemiologic research: data from three studies. Cancer Epidemiol. Biomarkers Prev.14, 2449–2453 (2005).
   PubMed Web of Science ®Google Scholar
• Manolio TA, Bailey-Wilson JE, Collins FS. Genes, environment and the value of propective cohort studies. Nat. Genet. Rev.7, 812–820 (2006).
   PubMed Web of Science ®Google Scholar
• Stern MP. Diabetes and atherosclerosis. Diabetes44, 369–374 (1995).
   PubMed Web of Science ®Google Scholar
• Laakso M. Diabetes and cardiovascular disease in Type 2 diabetes: challenge for treatment and prevention. J. Intern. Med.249, 225–235 (2001).
   PubMed Web of Science ®Google Scholar
• Chakravarti A, Little P. Nature, nurture, and human disease. Nature421, 412–414 (2003).
   PubMed Web of Science ®Google Scholar
• Tuomilehto J, Lindström J, Eriksson JG et al. Prevention of Type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med.344, 1343–1350 (2001).
   PubMed Web of Science ®Google Scholar
• Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of Type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med.346, 393–403 (2002).
   PubMed Web of Science ®Google Scholar
• Lindi VI, Uusitupa MI, Lindström J et al. for the Finnish Diabetes Prevention Study Group. Association of the Pro12Ala polymorphism in the PPAR-γ2 gene with 3-year incidence of Type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study. Diabetes51, 2581–2586 (2002).
   PubMed Web of Science ®Google Scholar
• Kubaszek A, Pihlajamäki J, Komarovski V et al. Promoter polymorphims of the TNF-α (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to Type 2 diabetes. The Finnish Diabetes Prevention Study. Diabetes52, 1872–1876 (2003).
   PubMed Web of Science ®Google Scholar
• Siitonen N, Lindström J, Eriksson J et al. Association of a deletion/insertion polymorphism in the α2B-adrenergic receptor gene with insulin secretion and Type 2 diabetes. The Finnish Diabetes Prevention Study. Diabetologia47, 1416–1424 (2004).
   Google Scholar
• Todorova B, Kubaszek A, Pihlajamäki J et al. The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to Type 2 diabetes: The Finnish Diabetes Prevention Study. J. Clin. Endocrinol. Metab.89, 2019–2023 (2004).
   Google Scholar
• Laukkanen O, Pihlajamäki J, Lindström J et al. for the Finnish Diabetes Prevention Study Group. Polymorphisms in the SUR1 (ABCC8) and Kir6.2 (KCNJ11) genes predict the conversion from impaired glucose tolerance to Type 2 diabetes. The Finnish Diabetes Prevention Study. J. Clin. Endocrinol. Metab.89, 6286–6290 (2004).
   PubMed Web of Science ®Google Scholar
• Laukkanen O, Lindström J, Eriksson J et al. for the Finnish Diabetes Prevention Study Group. Polymorphisms in the SLC2A2 (GLUT2) gene are associated with the conversion from impaired glucose tolerance to Type 2 diabetes: the Finnish Diabetes Prevention Study. Diabetes54, 2256–2260 (2005).
   PubMed Web of Science ®Google Scholar
• Laukkanen O, Pihlajamäki J, Lindström J et al. Common polymorphisms in the genes regulating the early insulin signalling pathway: effects on the weight change and the conversion from impaired glucose tolerance to Type 2 diabetes. The Finnish Diabetes Prevention Study. Diabetologia47, 871–877 (2004).
   Google Scholar
• Salopuro T, Pulkkinen L, Lindström J et al. for the Finnish Diabetes Prevention Study Group. Genetic variation in leptin receptor gene is associated with Type 2 diabetes and body weight: The Finnish Diabetes Prevention Study. Int. J. Obes.29, 1245–1251 (2005).
   Google Scholar
• Mager U, Lindi V, Lindström J et al. for the Finnish Diabetes Prevention Study. Association of the Leu72Met polymorphism of the grehlin gene with the risk of Type 2 diabetes in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study. Diabet. Med.23, 685–689 (2006).
   PubMed Web of Science ®Google Scholar
• Siitonen N, Pulkkinen L, Mager U et al. Association of sequence variations in the gene encoding adeponectin receptor 1 (ADIPOR1) with body size and insulin levels. The Finnish Diabetes Prevention Study. Diabetologia49, 1795–1805 (2006).
   Google Scholar
• Florez JC, Jablonski KA, Bayley N et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N. Engl. J. Med.355, 241–250 (2006).
   PubMed Web of Science ®Google Scholar
• Chiasson J-L, Josse RG, Gomis R et al. for the STOP-NIDDM Trial Research Group. Acarbose for prevention of Type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet359, 2072–2077 (2002).
   PubMed Web of Science ®Google Scholar
• Andrulionyte L, Zacharova J, Chiasson JL, Laakso M for the STOP-NIDDM Study Group. Common polymorphisms of the PPAR-γ2 (Pro12Ala) and PGC-1α (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to Type 2 diabetes in the STOP-NIDDM trial. Diabetologia47, 2176–2184 (2004).
   PubMed Web of Science ®Google Scholar
• Zacharova J, Chiasson JL, Laakso M for the STOP-NIDDM Study Group. The common polymorphisms (SNP +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to Type 2 diabetes: the STOP-NIDDM trial. Diabetes54, 893–899 (2005).
   PubMed Web of Science ®Google Scholar
• Zacharova J, Todorova BR, Chiasson JL, Laakso M for the STOP-NIDDM Study Group. The G-250 substitution in the promoter region of the hepatic lipase gene is associated with the conversion from impaired glucose tolerance to Type 2 diabetes: the STOP-NIDDM trial. J. Intern. Med.257, 185–193 (2005).
   PubMed Web of Science ®Google Scholar
• Andruolionyte L, Chiasson J-L, Laakso M. SNPs of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from IGT to Type 2 diabetes: the STOP-NIDDM trial. Diabetes55, 2148–2152 (2006).
   Google Scholar
• Weyrich P, Stefan N, Häring H-U, Laakso M, Fritsche A. Effect of genotype on success of lifestyle intervention in subjects at risk for Type 2 diabetes. J. Mol. Med.85, 107–117 (2007).
   PubMed Web of Science ®Google Scholar
• Nicklas BJ, van Rossum EF, Berman DM, Ryan AS, Dennis KE, Shuldiner AR. Genetic variation in the peroxisome proliferators-activated receptor-γ2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain. Diabetes50, 2172–2176 (2001).
   PubMed Web of Science ®Google Scholar
• Kahara T, Takamura T, Hayakawa T et al. PPARγ gene polymorphism is associated with exercise-mediated changes of insulin resistance in healthy men. Metabolism52, 209–212 (2003).
   Google Scholar
• Weiss EP, Kulaputana O, Ghiu IA et al. Endurance training-induced changes in the insulin response to oral glucose are associated with the peroxisome proliferators-activated receptor-γ2 Pro12Ala genotype in men but not in women. Metabolism Clin. Exp.54, 97–102 (2005).
   Google Scholar
• Adamo KB, Sigal RJ, Williams K et al. Influence of Pro12Ala peroxisome proliferator-activated receptor γ2 polymorphism on glucose response to exercise training in Type 2 diabetes. Diabetologia48, 1503–1509 (2005).
   Google Scholar
• Sladek R, Rocheleau G, Rung J et al. A genome-wide association study identifies novel risk loci for Type 2 diabetes. Nature445, 881–885 (2007).
   PubMed Web of Science ®Google Scholar